Troy Valentine

Mr Valentine has served as Chairman of the Board of Incannex Healthcare Inc. (Nasdaq: IXHL) since November 2023, having chaired Incannex Australia from December 2017. Across more than eight years of continuous chairmanship, he has led the company's growth from an early-stage ASX-listed business to a Nasdaq-listed clinical-stage pharmaceutical company. He has chaired a board through re-domiciliation from the ASX to a US corporate structure and a Nasdaq listing, with the SEC reporting, continued-listing obligations and US audit and governance standards that entails. He has governed the design, funding and execution of multiple clinical trial programs, including engagement with the U.S. Food and Drug Administration (FDA) and the Therapeutic Goods Administration (TGA). He has led a board through capital raisings across two jurisdictions and two investor bases, building a network of US and Australian institutional investors.